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Introduction

Metabolomics and lipidomics studies result in the
generation of vast quantities of data. Often the
analysis of this data is undertaken in closed software
environment with little to no access to enable the
assessment of the accuracy of the underlying
algorithms. As a result, data processed via different
software pipelines often provide slightly different
results further aggravating the existing problem of low
reproducibility of published results. As a first step
towards addressing this challenge, we began the
development of LipidAnalyst, an R based lipidomics
software pipeline. As a part of this project, we are
creating a simple statistical analysis and graphing
module in R called LipidAnalyst-Stat module to
generate statistically accurate high resolution figures
for use in publications. The results from the code
developed was independently validated using several
commercial software and also against a standard
lipidomic and metabolomic data analysis package,
namely Metaboanalyst, that is largely used in this
domain.

Results

Code generated in house demonstrated the same
results as those generated using commercial
software (e.g. JMP 15.0) but was significantly
different from results obtained by using the same data
through the MetaboAnalyst pipeline.

Figure 1: percentage of significant ANOVA for metabolites and
lipids using R script compared to Metaboanalyst.(46.4% in R
and 42.8% in Metaboanalyst). p-value calculated by using chisquare.

Methods

LipidAnalyst-Stat module is being developed using R
version 3.5.3 and currently includes the capability to
undertake statistical analyses (e.g. ANOVA) and
post-hoc tests (e.g. Tukey). In addition, the module
can also graph resultant information as high
resolution, publication quality, violin and box plots
with automated notation of statistical significance.
This module was tested for lipidomic and
metabolomic data and the results were compared
against commercial software and Metaboanalyst, a
primary data analysis software tool used in
metabolomic and lipidomic research. The data were
log transformed and Pareto centered for statistical
analysis and comparison of the two statistical
algorithms. We used the same data generated for
HFrEF Anakinra study and PCOS study study to test
the accuracy of the LipidAnalyst-Stat module
currently being developed.
Final results were
validated by using JMP.
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Table 1: Significant metabolites and lipids results
using Mytaboanalyst.
metabolites and
lipids

p-values
6.57E-12

PLACEBO-BASELINE;
ANAK02-BASELINE;
ANAK12-BASELINE;
ANAK12-ANAK02

glutamine

1.37E-0.5

PLACEBO-BASELINE;
ANAK02-BASELINE;
ANAK12-BASELINE;
ANAK12-PLACEBO;
ANAK12-ANAK02

histidine

1.96E-0.5

PLACEBO-BASELINE;
ANAK02-BASELINE;
ANAK12-BASELINE;
ANAK02-PLACEBO;
ANAK12-PLACEBO

CRP

5.42E-0.5

ANAK12-BASELINE;
ANAK12-PLACEBO;
ANAK12-ANAK02

uracil

0.0014648

PLACEBO-BASELINE;
ANAK02-BASELINE;
ANAK12-BASELINE;
ANAK02-PLACEBO;
ANAK12-PLACEBO

Table2: significant metabolites and lipids results
LipidAnalyst-Stat module.

Figure 2: percentage of significant Tukey HSD for metabolites
and lipids using R script compared to Metaboanalyst.(11.9% in
R and 57.14% in Metaboanalyst). p-value calculated by using
chi-square.

Figure 3: This figure represents the code that we used to plot
figure 1 by using multiple packages and functions in R.

p-values

Metaboanalyst
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Tukey HSD

glycine
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Tukey HSD

glycine

6.57E-12

ANAK02-BASELINE;
ANAK12-BASELINE;
BASELINE-PLACEBO

glutamine

1.37E-0.5

ANAK02-BASELINE;
BASELINE-PLACEBO

histidine

1.96E-0.5

ANAK02 -BASELINE;
ANAK12 - BASELINE;
BASELINE-PLACEBO

CRP
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ANAK02-ANAK12;
ANAK12-BASELINE;
ANAK12 PLACEBO

uracil

0.0014648

ANAK02-BASELINE;
ANAK12-BASELINE

Figure 4: Comparison of ANOVA results for myo-inositol
metabolite between Metaboanalyst and LipidAnalyst-Stat.
Metaboanalyst show statistical significant while in our
separately validated LipidAnalyst-Stat, the same level of
significance was not observed.

Figure 5: An example of a high-resolution figure (dpi=1200)
showing a pairwise comparison to display significant levels.

Conclusions

This study demonstrates the danger of blindly using
closed source software pipelines for the analysis of
lipidomic and metabolomic data without also
independently validating the analysis outcomes via
separate software. Alternatively, we propose the use
of open-source software such as what has been
created by us that is also independently validated
using multiple data such as JMP, wich 100% agree
with what we have. Such code can then be published
with the results to better enable transparency of data
analysis and greatly increasing the replicability of
results across different labs. Another limitation in
metaboanalyst is the limited availability of graphs,
graph designs and layouts, challenges that are being
overcome in LipidAnalyst-Stat.
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